Summary.
NMDA antagonists like AR-R15896 have been selected on the basis of their good therapeutic indices. As Dr. Rogawski has pointed out, there may be a number of molecular factors which can improve the therapeutic index of NMDA antagonists. In this paper we will consider three factors; use-dependence, low affinity/fast kinetics, and partial trapping.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received August 31, 1999 Accepted September 3, 1999
Rights and permissions
About this article
Cite this article
Lanthorn, T., Mealing, G. & Morley, P. Differences in degree of trapping between AR-R15896 and other uncompetitive NMDA receptor antagonists. Amino Acids 19, 173–175 (2000). https://doi.org/10.1007/s007260070046
Issue Date:
DOI: https://doi.org/10.1007/s007260070046